Nebraska has been active in promoting price transparency. The legislature continued to introduce new legislation in the 2017-2018 legislative term aimed at price transparency. In 2018, the state enacted the Direct Primary Care Pilot Program Act. This bill includes the Right to Shop Act, which would empower patients to choose the best value care by requiring insurance carriers to provide patients with the tools to find the best value and provide cash from shared savings. The legislature also passed laws to promote telehealth in the state.
In the past, Nebraska passed the 2014 Health Care Transparency Act, which created an advisory committee to investigate the creation of an all-payer claims database, and facilitate the reporting of health care and health quality data, provide for the facilitation of value-based, cost-effective purchasing of health care services by public and private purchasers and consumers, and includes provisions regarding claims and eligibility standards. In addition, Nebraska patients have the ability to petition hospitals for a written estimate of average charges for health care services, which promotes transparency and facilitates price shopping. One of Nebraska’s three insurance carriers, and the second largest cooperative non-profit under the ACA, is slated to be liquidated after financing dried up, which could be expected to lessen competition in the state.
The State Database
The Source tracks state activities impacting healthcare price and competition in both legislation and litigation in a searchable database to help stakeholders at the state level understand their legal and regulatory environment as they make efforts to improve access, quality, and efficiency, and reduce costs in healthcare.
LEGISLATION: The Database of State Laws Impacting Healthcare Cost and Quality (SLIHCQ), created by The Source on Healthcare Price & Competition and Catalyst for Payment Reform, catalogues state legislation governing price transparency, provider market power, provider payment, provider networks, and benefit design. The database also includes pharmaceutical legislation beginning in the 2017-2018 legislative session. *Note: Current legislative session bill updates are ongoing. Check back weekly for updates.
LITIGATION: The Source tracks major litigation and antitrust enforcement action by federal entities (FTC or DOJ), state attorney generals, and private parties in the main provider and insurer markets, particularly legal challenges of healthcare consolidation and anticompetitive contract provisions. Additionally, the database contains major pharmaceutical cases including legislation challenges and significant appellate cases.
Search the database across all jurisdictions on the State Overview page, or view and filter existing legislation or litigation on individual state pages. The database allows customized search and filter by keyword, status, and/or key issue category. *Multiple filter/selections enabled. Click here for User Guide.